LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $200.70 Million |
|---|---|
| Enterprise Value | $184.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 1.99 |
| Outstanding Shares | 47,336,060 |
| P/E Ratio | -10.07 |
|---|---|
| PEG | 1.26 |
| Price to Sales | 1.29 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.11 |
| Enterprise Value to EBIT | -9.63 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 1.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.65% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.84%▼ 36.84% |
|---|---|
| Total Invested | $1.64M▼ 97.45% |
| Investors Holding | 10▼ 97.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...